Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    20131302 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Advanced Chronic Myelogenous Leukemia (CML) - Follow On: Study of BMS-354825 in Subjects With CML
Conditions: Myeloid Leukemia, Chronic, Accelerated Phase;   Leukemia, Lymphoblastic, Acute, Philadelphia-Positive
Intervention: Drug: dasatinib

Indicates status has not been verified in more than two years